HIVEvs its industry peers
A metric-by-metric comparison of HIVE against SIC 6199 — valuation, growth, profitability, quality and total return, with each figure's rank within the peer group. Every value is Go-computed from SEC filings and delayed prices; ranks are sorted positions within the group only — descriptive, not advice.
| Company | Market cap | P/E (TTM) | P/B | P/S | Revenue growth (YoY) | Earnings growth (YoY) | EBIT margin | ROE | ROIC | Piotroski F | 1y total return | Dividend yield |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| HIVEThis | $788M#1 | — | 1.5x#2 | 2.6x#2 | 158.3%#2 | -4854.9%#4 | -48.3%#2 | -28.0%#3 | -28.3%#3 | — | — | — |
| GSMT | — | — | — | — | — | -36.1%#3 | -1810.9%#4 | — | -113.7%#4 | — | — | — |
| HKD | $207M#2 | 3.8x#1 | 0.8x#1 | 1.5x#1 | 565.7%#1 | 132.7%#2 | 0.8%#1 | 36.8%#1 | 0.2%#1 | — | -0.6%#1 | — |
| HTT | — | — | — | — | -80.2%#3 | 706.3%#1 | -972.6%#3 | 6.1%#2 | -4.7%#2 | — | -36.0%#2 | — |
Peer set: US filers sharing this company's SEC industry classification (SIC 6199). SIC is coarse — conglomerates and multi-segment companies map imperfectly. Values from SEC filings + delayed prices; ranks are within-group positions only. Market cap, P/E, P/B, P/S, 1y total return and dividend yield are computed from each member's latest snapshot price when the table is built (see as-of; snapshot prices can lag) — not live. Some peers are still being computed, so this table covers part of the group and ranks are within the rows shown; it fills in shortly. This table timed out mid-build, so it covers part of the group; ranks are within the rows shown and it fills in shortly. Table built 2026-08-04.
Source: SEC XBRL filings + delayed prices · ranks are within-group positions · For reference only · Not investment advice